Word

ELEVIDYS

Status

Pending

Status Code

641

Status Date

Wednesday, January 31, 2024

Serial Number

97925396

Mark Type

3000

Filing Date

Monday, May 8, 2023

Trademark Owner History

Sarepta Therapeutics, Inc.

Classifications

41 Medical training and teaching

5 Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

44 Medical services; providing health information

The mark consists of three alternately-shaded semi-circles increasing in size to an oval center and three alternately-shaded semi-circles decreasing in size on the other side of the oval center and followed by 'Elevidys.' The color gray is intended to show shading or contract only.
Color is not claimed as a feature of the mark.

Trademark Events

Jan 31, 2024

Notification Of Non-Final Action E-Mailed

Jan 31, 2024

Non-Final Action E-Mailed

Jan 31, 2024

Non-Final Action Written

Jan 31, 2024

Assigned To Examiner

Jun 7, 2023

Notice Of Design Search Code E-Mailed

Jun 6, 2023

New Application Office Supplied Data Entered

May 11, 2023

New Application Entered